10 January 2013
Plant Health Care plc
("Plant Health Care" or "the Company")
Trading Update
Plant Health Care plc, a leading provider of novel patent protected biological products to the global agriculture markets, provides the following post year-end update ahead of the announcement of its audited full year results for the year ended 31 December 2012 in March 2013.
The Board expects the results for the year to 31 December 2012 to show operating loss to be slightly better than expectations at approximately $6.5 million; and cash and short-term liquid investments better than expectations at $7.7 million. Revenue will be similar to last year at approximately $7.8 million.
A partnership agreement for foliar Harpin which was expected to be completed by the end of the year would have added significantly to the revenues for 2012. This agreement is now expected to be completed in the first quarter of 2013.
The Board continues to be excited about the ability of the Company to bring existing and new patented products to the market over the coming years. However, the precise timing of additional partnership agreements remains unpredictable.
~ ends ~
For further information, please contact:
Plant Health Care plc |
|
John Brady, Chief Executive Officer |
+1 603 525 3702 |
|
|
Stephen Weaver, Finance Director |
+1 412 826 5488 |
|
|
|
|
Nomura Code Securities |
+44 (0) 20 7776 1200 |
Chris Collins/ Clare Terlouw / Chris Golden |
|
|
|
|
|
Powerscourt |
+44 (0) 20 7250 1446 |
Paul Durman / Nick Dibden / Sophie Moate |
|
|
|
|
|
|
About Plant Health Care plc: Plant Health Care plc ("Plant Health Care") is a leading provider of novel patent protected biological products to the global agriculture markets. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/ mnemonic: PHC).
Further information is available at: www.planthealthcare.com.